153 results
Page 2 of 8
8-K
EX-4.3
sec5wdy0eh
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-10.1
5uyf4tqwdxsh1u
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-4.2
4klwdz2sidcxj16
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
424B5
mx805
21 Apr 23
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.3
g6ty8h uv8pswe26e
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.2
emn6yo0
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
p18q14l koxlo
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-3.3
g37ku
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.4
z4q0adqd
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.6
10ns7hhg pd
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
0i4mi 9nf3ny
5 Dec 22
Prospectus supplement
9:22am
425
8yqzovm 4yxc
28 Nov 22
Business combination disclosure
4:03pm
8-K
EX-99.1
oa5hybtr531bfwsh8ez
28 Nov 22
Regulation FD Disclosure
4:01pm
424B3
z5ied
10 Nov 22
Prospectus supplement
4:21pm